DNAJC5 and malaria: In multiple preclinical studies, the evaluation of the efficacy of CSP-based vaccines and anti-CSP antibodies has been performed using chimeric rodent malaria parasites expressing CSP from either P. falciparum or P. vivax (Espinosa et al., 2013; Gimenez et al., 2017; Salman et al., 2017; Vijayan et al., 2017; de Camargo et al., 2018; Marques et al., 2020).